Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease
about
Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease
description
clinical trial
@en
klinisch onderzoek
@nl
name
Clofarabine, Melphalan, and Th ...... ologic Cancer or Other Disease
@en
type
label
Clofarabine, Melphalan, and Th ...... ologic Cancer or Other Disease
@en
prefLabel
Clofarabine, Melphalan, and Th ...... ologic Cancer or Other Disease
@en
P4844
P1476
A Phase I/II Dose Escalation T ...... anced Hematologic Malignancies
@en
P3098
NCT00423514
P580
2006-11-01T00:00:00Z
P582
2019-11-01T00:00:00Z